Regular Article
Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses

https://doi.org/10.1053/jhin.2001.1143Get rights and content

Abstract

The prevalence of hepatitis A, B and C antibodies was measured in a group of healthcare workers (HCWs) at increased risk of occupational acquisition of blood-borne viruses (N=402) from a large, urban referral hospital in South Africa. The aims of this study were to determine the immunity of HCWs to these agents and to recommend policy for the protection of HCWs against occupational exposure to viral hepatitis in this country. Race, sex and age were shown to be important factors influencing the presence of hepatitis A (HAV) antibodies. Most black HCWs (96.2%) are protected from HAV infection. Females have significantly higher HAV antibodies compared with males and antibodies increase with increasing age. Hepatitis B antibodies (anti-HBs) were found in 30.6% of HCWs. Anti-HBs levels were significantly associated with a past history of HBV vaccination. However, only a small proportion of HCWs (21.2%) could remember ever being immunized against HBV. For those individuals that did receive HBV vaccination (N=83), the mean number of years since their last vaccine was 6.2 years (SD±3.5). HCV antibodies were found in 1.8% of HCWs at increased risk of occupational exposure. It was not possible to define whether these infections were occupationally acquired but genotyping of the HCV (in two of seven cases) showed genotype 5, the predominant South African genotype. New recommendations for the prevention of viral hepatitis in HCWs in South Africa are made, including pre-employment screening for HAV based on self-selection criteria, universal anti-HBs screening with HBV booster vaccination. HCV recommendations are based on appropriate education of HCWs about this infection and its prevention and a standardized post-exposure testing protocol.

References (24)

  • A Widell et al.

    Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C virus antibody assays

    J Med Virol

    (1991)
  • Morbidity and Mortality Weekly Report

    (1996)
  • Cited by (35)

    • High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa

      2016, Vaccine
      Citation Excerpt :

      Immunisation of HCWs against HBV is crucial for infection control, thus the South African National Department of Health (SANDoH) recommends all HCWs be vaccinated against HBV before being exposed to patients. However, limited studies investigating antibodies against HBsAg (anti-HBs) among South African HCWs have found sub-optimal levels of protection against HBV, with only 30.6–52.4% having protective levels of anti-HBs (i.e. anti-HBs ⩾ 10mIU/ml) [5,6]. This study aimed to determine the prevalence of HBV markers of susceptibility, protection, exposure and infection in HCWs working in two provinces of South Africa, stratified by vaccination status.

    • Need for a comprehensive, consistently applied national hepatitis B vaccination policy for healthcare workers in higher educational institutions: A case study from South Africa

      2013, Journal of Hospital Infection
      Citation Excerpt :

      As the HB vaccine was only introduced into the Expanded Program on Immunization of South Africa in 1995, being administered to babies at six, 10 and 14 weeks of age,12 it is likely that none of the student HCWs enrolled at higher educational institutions (HEIs) in South Africa were ever vaccinated against HBV as children. Although the South African Department of Health strongly recommends HB vaccination for HCWs, there is a need for a consistent national policy, as previous studies have found that hospital policies are inconsistent10 and HB vaccination coverage is suboptimal.10,13 An earlier study reported that only 21.2% of HCWs at high risk of HBV exposure remembered ever being vaccinated,10 while a recent study found that 67.9% had received at least one dose of HB vaccine, but only 19.9% were fully vaccinated.13

    • An update after 16 years of hepatitis B vaccination in South Africa

      2012, Vaccine
      Citation Excerpt :

      Unfortunately HBV DNA testing is not routinely conducted on such cases. Although the SADoH recommends HB vaccination for HCWs, it has not been made mandatory [20,29,68]. An earlier study from Gauteng, South Africa found that the majority of HCWs at high risk for HBV are not vaccinated, with only 21.2% remembering ever being vaccinated [68].

    • Hepatitis B vaccination coverage in healthcare workers in Gauteng Province, South Africa

      2011, Vaccine
      Citation Excerpt :

      Thus South African HCWs are at high risk for occupational exposure to HBV, yet in 2002 a study conducted in Johannesburg Hospital in Gauteng Province found that only 30.6% were protected (either from natural infection or vaccination), and only 21.2% could recall being vaccinated [11]. Although the SA National Department of Health (SANDoH) recommends vaccinating all HCWs against HBV, this is not mandatory and there is no national policy in place for HB vaccination of HCWs [11]. In May 2010, the 63rd World Health Assembly adopted a resolution prioritising the global prevention and control of viral hepatitis, and recommended increasing the HB vaccination coverage of HCWs [12].

    View all citing articles on Scopus
    f1

    Author for correspondence: Dr E. Vardas, Perinatal HIV Research Unit, HIV/AIDS Vaccine Division, PO Bertsham 2013, Johannesburg, South Africa. Fax: 27(11) 9383973; E-mail:[email protected]

    View full text